203 related articles for article (PubMed ID: 12556962)
41. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
42. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients.
Crocetti E; Carli P
Eur J Cancer Prev; 2004 Feb; 13(1):33-7. PubMed ID: 15075786
[TBL] [Abstract][Full Text] [Related]
43. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.
Cerhan JR; Janney CA; Vachon CM; Habermann TM; Kay NE; Potter JD; Sellers TA; Folsom AR
Am J Epidemiol; 2002 Sep; 156(6):527-35. PubMed ID: 12226000
[TBL] [Abstract][Full Text] [Related]
44. Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study.
McBride A; Daniel S; Driessen MT; Szende A; Choudhry A; Tian M; Ariely R; Thompson S
Leuk Res; 2021 Dec; 111():106671. PubMed ID: 34530254
[TBL] [Abstract][Full Text] [Related]
45. A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma.
Farma JM; Zager JS; Barnica-Elvir V; Puleo CA; Marzban SS; Rollison DE; Messina JL; Sondak VK
Ann Surg Oncol; 2013 Apr; 20(4):1360-4. PubMed ID: 23179994
[TBL] [Abstract][Full Text] [Related]
46. Competing risks analysis of Merkel cell carcinoma with concurrent chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Nguyen KA; Maloney NJ; Yang JJ; Bach DQ; Zaba LC
Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755954
[TBL] [Abstract][Full Text] [Related]
47. An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis?
Bloom R; Amber KT; Nouri K
Australas J Dermatol; 2016 Aug; 57(3):e114-6. PubMed ID: 25801041
[TBL] [Abstract][Full Text] [Related]
48. Frequency and timing of other primary cancers in patients with chronic lymphocytic leukemia (CLL): a 17-year longitudinal study.
Akhtar OS; Groman A; Singh A; Ghione P; Lund I; Hernandez-Ilizaliturri FJ; Torka P
Leuk Lymphoma; 2022 May; 63(5):1127-1136. PubMed ID: 35152821
[TBL] [Abstract][Full Text] [Related]
49. Incidence of second primary malignancies in relapsed/refractory B-cell non-Hodgkin's lymphoma patients in England.
Miret M; Anderson A; Hindocha P; Cirneanu L; Lymperopoulou C; Markov E; Kizito W; Vegni FE
Leuk Res; 2023 Apr; 127():107042. PubMed ID: 36812661
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders.
Brown JR; Neuberg D; Phillips K; Reynolds H; Silverstein J; Clark JC; Ash M; Thompson C; Fisher DC; Jacobsen E; LaCasce AS; Freedman AS
Br J Haematol; 2008 Nov; 143(3):361-8. PubMed ID: 18729853
[TBL] [Abstract][Full Text] [Related]
51. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
52. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
53. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
[TBL] [Abstract][Full Text] [Related]
54. Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study.
Royle JA; Baade PD; Joske D; Girschik J; Fritschi L
Br J Cancer; 2011 Sep; 105(7):1076-81. PubMed ID: 21847118
[TBL] [Abstract][Full Text] [Related]
55. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
[TBL] [Abstract][Full Text] [Related]
56. Increased risk of melanoma in patients with chronic lymphocytic leukaemia: systematic review and meta-analysis of cohort studies.
Olsen CM; Lane SW; Green AC
Melanoma Res; 2016 Apr; 26(2):188-94. PubMed ID: 26630660
[TBL] [Abstract][Full Text] [Related]
57. Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Tietsche de Moraes Hungria V; Chiattone C; Pavlovsky M; Abenoza LM; Agreda GP; Armenta J; Arrais C; Avendaño Flores O; Barroso F; Basquiera AL; Cao C; Cugliari MS; Enrico A; Foggliatto LM; Galvez KM; Gomez D; Gomez A; de Iracema D; Farias D; Lopez L; Mantilla WA; Martínez D; Mela MJ; Miguel CE; Ovilla R; Palmer L; Pavlovsky C; Ramos C; Remaggi G; Santucci R; Schusterschitz S; Sossa CL; Tuna-Aguilar E; Vela J; Santos T; de la Mora O; Machnicki G; Fernandez M; Barreyro P
J Glob Oncol; 2019 Nov; 5():1-19. PubMed ID: 31774711
[TBL] [Abstract][Full Text] [Related]
58. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia.
Cerhan JR; Wallace RB; Dick F; Kemp J; Parker AS; Zheng W; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):361-8. PubMed ID: 11319177
[TBL] [Abstract][Full Text] [Related]
59. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.
Lens MB; Newton-Bishop JA
Ann Oncol; 2005 Mar; 16(3):460-5. PubMed ID: 15642704
[TBL] [Abstract][Full Text] [Related]
60. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.
Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS
Leuk Lymphoma; 2004 Mar; 45(3):507-13. PubMed ID: 15160912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
